Form 4 for LH Labcorp
Accepted 2025-03-31 00:00:00 ET · period of report 2025-03-27 · accession 0001127602-25-010624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2025-03-28 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale | $231.67 | -2,635 | 4,960 | -35% | -$610.5K | |
| 2025-03-31 | 2025-03-27 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | A - Grant | $0.00 | +4,840 | 9,800 | +98% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $231.67 | -2,205 | 7,595 | -22% | -$510.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-28 | S | D | 2,635 | $231.67 | 4,960.14 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-27 | A | A | 4,840 | $0.00 | 9,800.14 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-27 | F | D | 2,205 | $231.67 | 7,595.14 | D | — | — |